共 50 条
Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report
被引:3
|作者:
Jung, B. -H.
[1
]
Park, J. -I.
[1
]
Lee, S. -G.
[2
]
机构:
[1] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Surg, 875 Haeundae Ro, Busan 48108, South Korea
[2] Univ Ulsan, Asan Med Ctr, Div Hepatobiliary Surg & Liver Transplantat, Dept Surg,Coll Med, Seoul, South Korea
关键词:
DRUG-INDUCED HEPATOTOXICITY;
RISK-FACTORS;
INFECTION;
RECIPIENTS;
POLYMORPHISMS;
MANAGEMENT;
HEPATITIS;
DIAGNOSIS;
THERAPY;
FAILURE;
D O I:
10.1016/j.transproceed.2018.02.013
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Background. Although active tuberculosis (TB) is considered a contraindication for liver transplantation (LT), this is the only treatment in patients with liver failure and concurrent active TB. We report a case with successful urgent living-donor LT for irreversible liver failure in the presence of active TB. Case Presentation. A 48-year-old man, with a history of decompensated alcoholic liver cirrhosis, was presented with stupor. At admission, his consciousness had deteriorated to semi-coma, and his renal function also rapidly deteriorated to hepatorenal syndrome. A preoperative computed tomography scan of the chest revealed several small cavitary lesions in both upper lobes, and acid-fast bacillus stain from his sputum was graded 2+. Adenosine deaminase levels from ascites were elevated, suggesting TB peritonitis. A first-line anti-TB drug regimen was started immediately (rifampin, isoniazid, levofloxacin, and amikacin). An urgent living-donor LT was performed 2 days later. After LT, the regimen was changed to second-line anti-TB drugs (amikacin, levofloxacin, cycloserine, and pyridoxine). The sputum acid fast bacillus stain tested negative on postoperative day 10. His liver function remained well preserved, even after the reversion to first-line anti-TB treatment. The patient recovered without any anti-TB medication-related complications and was discharged. Conclusions. LT can be prudently performed as a life-saving option, particularly for patients with liver failure and concurrent active TB.
引用
收藏
页码:910 / 914
页数:5
相关论文